CClinicalTrials.gg
CompletedNCT06723613Updated Mar 20, 2025

Exercise Program to Increase Breast Milk

An interventional study of Exercise group in Maternal Behavior, Breastfeeding, Exclusive and Breast Milk Expression, sponsored by Selcuk University. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-20.

Sponsored by Selcuk University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
122
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

In this study, the effects of an exercise program aimed at increasing breast milk on breastfeeding self-efficacy, breastfeeding success, and breast milk quantity will be evaluated.

Read the detailed description

The research is a randomized controlled trial. The research will be conducted with 122 mothers who are in their 8th week postpartum and have healthy babies. Mothers in the exercise group will be given 1 hour (60 minutes) of exercise to increase breast milk three times a week for 6 weeks. The control group will be given routine breastfeeding education. Data will be collected using a sociodemographic form, Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), LATCH- Breastfeeding Charting system, IMDAT: a tool for assessing the level of maternal milk intake scale.

02

Conditions studied

  • Maternal Behavior
  • Breastfeeding, Exclusive
  • Breast Milk Expression

Keywords

  • Breastfeeding Self-Efficacy Scale
  • Breastfeeding problems
  • Breast Milk Quantity
03

In context

Lead sponsor

Selcuk University is the lead sponsor of 248 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Those who are over 18 years old,
  • Who gave birth at term pregnancy (38-42 weeks),
  • Who have a healthy baby,
  • Who are between 8 weeks postpartum.

Exclusion criteria

Exclusion Criteria:

  • Those with diagnosed mental illness (e.g., antidepressants, antianxiety or antipsychotic medications),
  • Those with chronic systemic illnesses,
  • Those with physical illnesses that may prevent them from exercising,
  • Those with any postpartum complications (hemorrhage, postpartum infection, mastitis, thromboembolic disease or postpartum psychiatric disorder).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
122 participants (actual)

Study arms

  • No intervention
    Placebo group

    Mothers in the control group will not exercise and will receive routine breastfeeding counseling. In the 8th and 14th weeks after birth, mothers will be subjected to; Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), LATCH- Breastfeeding Charting system, IMDAT: a tool for assessing the level of maternal milk intake scales.

  • Experimental
    Intervention Group

    Primiparous mothers assigned to the exercise group will attend classes in groups of 8-10. Mothers will be given 1 hour (120 minutes) of exercises to increase breast milk three times a week for 6 weeks. The total training time is 18 hours. Each session will include 60 minutes of warm-up and stretching exercises and 30 minutes of relaxation exercises.

    Behavioral: Exercise group

Interventions

  • BehavioralExercise group

    Primiparous mothers assigned to the exercise group will attend classes in groups of 8-10. Mothers will be given 1 hour (120 minutes) of exercises to increase breast milk three times a week for 6 weeks. The total training time is 18 hours. Each session will include 60 minutes of warm-up and stretching exercises and 30 minutes of relaxation exercises. Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), LATCH-Breastfeeding Record System, IMDAT: Breast milk intake level assessment tool scales will be applied to mothers before exercise (8th week after birth) and after exercise (14th week).

06

What researchers measure

Primary outcomes

  1. Comparison of mothers' sociodemographic characteristics with survey before intervention

    Mothers' sociodemographic characteristics will be collected through surveys and compared and reported

    Time frame: 3 months

  2. Comparison of mothers' Breastfeeding Self-Efficacy Scale averages by groups

    Breastfeeding Self-Efficacy Scale will be applied to mothers. Breastfeeding Self-Efficacy Scale is 14-70 points (min-max) and as the score increases, it shows that mothers' breastfeeding self-sufficiency increases.

    Time frame: 3 months

  3. Comparison of mothers' LATCH- Breastfeeding Charting system averages by groups

    LATCH- Breastfeeding Charting system will be applied to mothers. LATCH- Breastfeeding Charting system is 0-10 points (min-max) and as the score increases, it shows that the mothers' LATCH score increases.

    Time frame: 3 months

  4. Comparison of mothers' IMDAT: a tool for assessing the level of maternal milk intake averages by group.

    IMDAT will be applied to mothers. IMDAT is 0-10 points (min-max) and the higher the score, the better the intake of breast milk.

    Time frame: 3 months

07

Study locations

1 site
  • Seyhan Çankaya
    Konya, 42250, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06723613
Lead sponsor
Selcuk University
Responsible party
Seyhan Çankaya (Principal Investigator Seyhan Çankaya, Selcuk University) — Principal investigator
First posted
Dec 9, 2024
Start date
Jan 1, 2025
Primary completion
Mar 1, 2025
Completion
Mar 1, 2025
Last update
Mar 20, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion